These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medicines to remain with European Commission health directorate. Watson R BMJ; 2014 Oct; 349():g6514. PubMed ID: 25355097 [No Abstract] [Full Text] [Related]
4. [France in the European cooperation for the technological evaluation of health products]. Meyer F Med Sci (Paris); 2018 May; 34 Hors série n°1():57-59. PubMed ID: 29911568 [No Abstract] [Full Text] [Related]
5. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819 [TBL] [Abstract][Full Text] [Related]
6. Prescription drug approval in Canada: a risk-benefit analysis. Davis T J Can Dent Assoc; 1995 Jul; 61(7):578-9. PubMed ID: 7627885 [No Abstract] [Full Text] [Related]
7. [The role of the Danish Medical Products Agency in clinical trials]. Simonsen AC Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821 [TBL] [Abstract][Full Text] [Related]
8. Profile: Thomas Lönngren. Louët S Nat Biotechnol; 2004 Nov; 22(11):1341. PubMed ID: 15529143 [No Abstract] [Full Text] [Related]
9. European Medicines Agency is attacked over proposal to allow technology assessment bodies to sell advice to drug industry. Wise J BMJ; 2014 Jul; 349():g4674. PubMed ID: 25033980 [No Abstract] [Full Text] [Related]
10. European Medicines Agency: Approval of new glucose-lowering medicines for type 2 diabetes. Bailey CJ Diabetes Obes Metab; 2018 Sep; 20(9):2057-2058. PubMed ID: 29756322 [No Abstract] [Full Text] [Related]
11. Drug approval and research assessment: arguments for reform. Abbasi K J R Soc Med; 2016 Sep; 109(9):323. PubMed ID: 27534705 [No Abstract] [Full Text] [Related]
12. Drug evaluation and approval process in the European Union. San Miguel MT; Vargas E Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405 [No Abstract] [Full Text] [Related]
13. [Does collaboration inside the European Union improve Finnish drug safety?]. Palva E Duodecim; 2000; 116(24):2810-1. PubMed ID: 12077885 [No Abstract] [Full Text] [Related]
14. NICE supports allowing technology assessment bodies to provide advice to drug industry. Longson C; Crabb N; Osipenko L BMJ; 2014 Aug; 349():g5035. PubMed ID: 25121499 [No Abstract] [Full Text] [Related]
16. For the European Medicines Agency, a decade of challenges. Rice M J Natl Cancer Inst; 2005 Oct; 97(19):1403-5. PubMed ID: 16204689 [No Abstract] [Full Text] [Related]
17. Premarketing trials: too few patients. Prescrire Int; 2014 Oct; 23(153):251. PubMed ID: 25964980 [No Abstract] [Full Text] [Related]
18. European Medicines Agency: leave the UK but remain the same. Garattini L; Curto A J R Soc Med; 2016 Sep; 109(9):324-5. PubMed ID: 27609795 [No Abstract] [Full Text] [Related]
19. [Experiences of the drug approval processes in the European Union]. Pasanen M; Toivonen M Duodecim; 2000; 116(24):2817-22. PubMed ID: 12077887 [No Abstract] [Full Text] [Related]
20. European Medicines Agency pledges to publish clinical reports. Watson R BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699 [No Abstract] [Full Text] [Related] [Next] [New Search]